IL195653A0 - Oral pharmaceutical composition of a poorly water-soluble active substance - Google Patents
Oral pharmaceutical composition of a poorly water-soluble active substanceInfo
- Publication number
- IL195653A0 IL195653A0 IL195653A IL19565308A IL195653A0 IL 195653 A0 IL195653 A0 IL 195653A0 IL 195653 A IL195653 A IL 195653A IL 19565308 A IL19565308 A IL 19565308A IL 195653 A0 IL195653 A0 IL 195653A0
- Authority
- IL
- Israel
- Prior art keywords
- pharmaceutical composition
- active substance
- poorly water
- oral pharmaceutical
- soluble active
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/485—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Epidemiology (AREA)
- Inorganic Chemistry (AREA)
- Hematology (AREA)
- Hospice & Palliative Care (AREA)
- Diabetes (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US81557906P | 2006-06-22 | 2006-06-22 | |
IN1473DE2006 | 2006-06-22 | ||
EP06115881 | 2006-06-22 | ||
PCT/EP2007/056207 WO2007147873A1 (en) | 2006-06-22 | 2007-06-21 | Oral pharmaceutical composition of a poorly water-soluble active substance |
Publications (1)
Publication Number | Publication Date |
---|---|
IL195653A0 true IL195653A0 (en) | 2009-09-01 |
Family
ID=38475974
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL195653A IL195653A0 (en) | 2006-06-22 | 2008-12-02 | Oral pharmaceutical composition of a poorly water-soluble active substance |
Country Status (9)
Country | Link |
---|---|
EP (1) | EP2037890A1 (en) |
JP (1) | JP2009541267A (en) |
KR (1) | KR20090033246A (en) |
AU (1) | AU2007263016A1 (en) |
CA (1) | CA2654243A1 (en) |
EA (1) | EA200970045A1 (en) |
IL (1) | IL195653A0 (en) |
NO (1) | NO20090265L (en) |
WO (1) | WO2007147873A1 (en) |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1397160A1 (en) * | 2001-04-30 | 2004-03-17 | Shire Laboratories Inc. | Pharmaceutical composition including ace/nep inhibitors and bioavailability enhancers |
AR038681A1 (en) * | 2002-02-14 | 2005-01-26 | Solvay Pharm Bv | ORAL FORMULATION OF SOLID SOLUTION OF A POVERLY SOLUBLE ACTIVE SUBSTANCE IN WATER |
WO2004062692A1 (en) * | 2003-01-13 | 2004-07-29 | Solvay Pharmaceuticals B.V. | Formulation of poorly water-soluble active substances |
TW200633713A (en) * | 2004-12-23 | 2006-10-01 | Solvay Pharm Bv | Oral immediate release formulation of a poorly water-soluble active substance |
WO2007054975A1 (en) * | 2005-11-08 | 2007-05-18 | Panacea Biotec Ltd | Pharmaceutical compositions for the treatment of cardiovascular and other associated disorders |
-
2007
- 2007-06-21 WO PCT/EP2007/056207 patent/WO2007147873A1/en active Application Filing
- 2007-06-21 EP EP07730293A patent/EP2037890A1/en not_active Ceased
- 2007-06-21 AU AU2007263016A patent/AU2007263016A1/en not_active Abandoned
- 2007-06-21 EA EA200970045A patent/EA200970045A1/en unknown
- 2007-06-21 KR KR1020097001506A patent/KR20090033246A/en not_active Application Discontinuation
- 2007-06-21 CA CA002654243A patent/CA2654243A1/en not_active Abandoned
- 2007-06-21 JP JP2009515884A patent/JP2009541267A/en not_active Withdrawn
-
2008
- 2008-12-02 IL IL195653A patent/IL195653A0/en unknown
-
2009
- 2009-01-16 NO NO20090265A patent/NO20090265L/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
EP2037890A1 (en) | 2009-03-25 |
WO2007147873A1 (en) | 2007-12-27 |
KR20090033246A (en) | 2009-04-01 |
AU2007263016A1 (en) | 2007-12-27 |
EA200970045A1 (en) | 2009-06-30 |
NO20090265L (en) | 2009-01-22 |
JP2009541267A (en) | 2009-11-26 |
CA2654243A1 (en) | 2007-12-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA200900345B (en) | Preparation of pharmaceutical formulations | |
IL206159A0 (en) | Oral pharmaceutical dosage forms | |
ZA200810164B (en) | Sustained release pharmaceutical dosage form containing phenylphrine | |
ZA200707022B (en) | A solid pharmaceutical dosage formulation | |
IL197204A0 (en) | Pharmaceutical compositions containing a weakly basic drug and a timed pulsatile release coating | |
ZA200809002B (en) | Cycloalkylamino acid derivatives and pharmaceutical compositions thereof | |
EP1968554A4 (en) | Bioadhesive drug formulations for oral transmucosal delivery | |
IL215988A (en) | Self micro-emulsifying oral pharmaceutical composition of a hydrophilic drug and preparation method thereof | |
EP2112925A4 (en) | Solid pharmaceutical dosage formulations | |
HUE063083T2 (en) | Pharmaceutical compositions comprising nilotinib | |
ME01614B (en) | Pharmaceutical composition of a patent hcv inhibitor for oral administration | |
AP2008004671A0 (en) | Cycloalkylamino acid derivatives and pharmaceutical compositions thereof | |
EP2011482A4 (en) | Solid preparation for oral application | |
EP2078731A4 (en) | Pharmaceutical composition comprising anti-hb-egf antibody as active ingredient | |
PL2059260T3 (en) | Pharmaceutical compositions comprising hGH for oral delivery | |
GB0614586D0 (en) | Pharmaceutical Formulation | |
EP2001400A4 (en) | Oral formulations of glycyl-2-methylprolyl-glutamate | |
EP2062579A4 (en) | Solid pharmaceutical composition for oral administration comprising optically stable ramosetron | |
ZA200807486B (en) | Medicament formulations comprising fluoroquinolones | |
EP2206519A4 (en) | Medicinal preparation for oral administration | |
EP2012705A4 (en) | Pharmaceutical formulations for iontophoretic drug delivery | |
IL198160A0 (en) | Pharmaceutical formulations | |
PL1848439T3 (en) | Oral immediate release formulation of a poorly watersoluble active substance | |
IL195726A0 (en) | Pharmaceutical compositions comprising a combination of piperidinoalkanol and decongestant | |
IL191922A0 (en) | Pharmaceutical formulations of oxcarbazepine and methods for its preparation |